Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Biopsy, Dermatitis atopic, Ear discomfort, Hypersensitivity, Skin cancer
Clinical narrative: skins cancer, Squamous cell identified in a biopsy; had a sore injection site reaction the day after getting vaccinated, nothing out of the ordinary after both vaccine; has Atopic dermatitis Eczema cover his entire back, both legs, both ankles and both feet,/got eczema atopic dermatitis in his legs, and  was an immune allergic reaction; After the vaccination got a breakout on his ear; immune allergic reaction; This spontaneous case was reported by a patient and describes the occurrence of SKIN CANCER (skins cancer, Squamous cell identified in a biopsy) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced SKIN CANCER (skins cancer, Squamous cell identified in a biopsy) (seriousness criterion medically significant), VACCINATION SITE REACTION (had a sore injection site reaction the day after getting vaccinated, nothing out of the ordinary after both vaccine), DERMATITIS ATOPIC (has Atopic dermatitis Eczema cover his entire back, both legs, both ankles and both feet,/got eczema atopic dermatitis in his legs, and  was an immune allergic reaction), EAR DISCOMFORT (After the vaccination got a breakout on his ear) and HYPERSENSITIVITY (immune allergic reaction). At the time of the report, SKIN CANCER (skins cancer, Squamous cell identified in a biopsy), VACCINATION SITE REACTION (had a sore injection site reaction the day after getting vaccinated, nothing out of the ordinary after both vaccine), DERMATITIS ATOPIC (has Atopic dermatitis Eczema cover his entire back, both legs, both ankles and both feet,/got eczema atopic dermatitis in his legs, and  was an immune allergic reaction), EAR DISCOMFORT (After the vaccination got a breakout on his ear) and HYPERSENSITIVITY (immune allergic reaction) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: skins cancer, Squamous cell identified in a biopsy.         Patient had no allergies (medications, food and other products). Patient did not ever had COVID positive test or diagnosis. Adverse event cause patient to go Emergency Room. Patient did not experienced a similar event in the past. Symptoms improved, but not over yet. Concomitant medication had prescription for high blood pressure. Treatment information was not provided.  Company Comment: This spontaneous case concerning a 76-year-old male patient with no reported medical history, who experienced the unexpected, serious, event of Skin Cancer which was medically significant and the non-serious events of Dermatitis Atopic, Vaccination Site Reaction, Hypersensitivity, and Ear Discomfort. The events occurred on an unknown date after receiving a dose of mRNA-1273 Vaccine. The patient had a sore injection site reaction the date after getting vaccinated from both vaccines. He also had Atopic dermatitis Eczema covered his entire back, both legs, both ankles and both feet with weeping. He also had a breakout on his ear. Squamous cell Skin Cancer was identified in a biopsy. No further information on risk factors, co morbidities, clinical course and management of the events was available in the report. It was reported that the outcome of the events has not resolved. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to MOD-2022-611780 (Patient Link).; Sender's Comments: This spontaneous case concerning a 76-year-old male patient with no reported medical history, who experienced the unexpected, serious, event of Skin Cancer which was medically significant and the non-serious events of Dermatitis Atopic, Vaccination Site Reaction, Hypersensitivity, and Ear Discomfort. The events occurred on an unknown date after receiving a dose of mRNA-1273 Vaccine. The patient had a sore injection site reaction the date after getting vaccinated from both vaccines. He also had Atopic dermatitis Eczema covered his entire back, both legs, both ankles and both feet with weeping. He also had a breakout on his ear. Squamous cell Skin Cancer was identified in a biopsy. No further information on risk factors, co morbidities, clinical course and management of the events was available in the report. It was reported that the outcome of the events has not resolved. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.